Adiponectin in Chronic Thromboembolic Pulmonary Hypertension

Circ J. 2018 Apr 25;82(5):1466-1468. doi: 10.1253/circj.CJ-17-1434. Epub 2018 Mar 21.

Abstract

Background: The correlation between serum adiponectin concentration and hemodynamics or certain metabolic markers in patients with chronic thromboembolic pulmonary hypertension (CTEPH) is unknown.Methods and Results:We enrolled 30 CTEPH patients who underwent interventional therapy of balloon pulmonary angioplasty or pulmonary endarterectomy. Serum adiponectin concentrations positively correlated with B-type natriuretic peptide (BNP) concentrations, pulmonary vascular resistance, and mean pulmonary arterial pressure. After the therapeutic interventions, serum adiponectin concentrations improved and changes in serum adiponectin concentrations significantly correlated with changes in BNP concentrations.

Conclusions: Adiponectin can be a useful marker for the severity of CTEPH.

Keywords: Adiponectin; B-type natriuretic peptide; Chronic thromboembolic pulmonary hypertension.

Publication types

  • Clinical Trial

MeSH terms

  • Adiponectin / blood*
  • Aged
  • Angioplasty, Balloon*
  • Biomarkers / blood
  • Chronic Disease
  • Endarterectomy*
  • Female
  • Humans
  • Hypertension, Pulmonary* / blood
  • Hypertension, Pulmonary* / surgery
  • Male
  • Middle Aged
  • Natriuretic Peptide, Brain / blood*
  • Severity of Illness Index

Substances

  • ADIPOQ protein, human
  • Adiponectin
  • Biomarkers
  • Natriuretic Peptide, Brain